Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
BUSERELIN ACETATE
Intervet Ireland Limited
QH01CA90
BUSERELIN ACETATE
4 Microgram/ML
Solution for Injection
POM
Porcine
Buserelin
Hormone
Authorised
2013-12-20
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Porceptal 4 micrograms/ml solution for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection A clear, colourless solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (gilts and sows) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction of ovulation after oestrus synchronisation by weaning (sows) or by administration of a progestin (gilts) to be used as part of a single fixed time artificial insemination program. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Buserelin is given after oestrus synchronisation. In gilts, buserelin is given after progestin treatment. Provided that the progestin treatment is ended simultaneously in a group of gilts, it causes a synchronisation of oestrus in the treated animals. In sows, oestrus synchronisation is achieved naturally by weaning. Insemination can be done at 30-33 hours after buserelin injection. When using this product, the animals should be checked for signs of oestrus at the time of artificial insemination. Therefore the presence of the boar is recommended. It may happen that negative energy balance during lactation is associated with mobilisation of body reserves with a large drop in backfat thickness (more than approximately 30 %). In such animals, oestrus and ovulation may be delayed and these animals should be managed and bred on a case by case basis. Per ml: ACTIVE SUBSTANCE: Buserelin acetate 4.2 µg (corresponding to 4 µg buserelin) EXCIPIENTS: Benzyl alcohol E1519 20.0 mg For a full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Da Read the complete document